4//SEC Filing
Callori Fred 4
Accession 0000899243-21-004752
CIK 0001454789other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:45 PM ET
Size
10.7 KB
Accession
0000899243-21-004752
Insider Transaction Report
Form 4
Callori Fred
Director
Transactions
- Award
Series X Convertible Preferred Stock
2021-02-01$3009.53/sh+1,617$4,866,410→ 30,920 total(indirect: By Perceptive Xontogeny Venture Fund, LP)→ Common Stock (1,617,000 underlying)
Footnotes (2)
- [F1]Upon stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of common stock, each share of Series X Non-Voting Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.
- [F2]On February 1, 2021, Issuer completed its private placement pursuant to that certain Stock Purchase Agreement dated January 27, 2021 (the "Private Placement"). In connection with the Private Placement, a limited partnership (the "Fund") in which the Reporting Person has an indirect pecuniary interest purchased shares of Series X Convertible Preferred Stock. The Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of his pecuniary interest therein.
Issuer
CATABASIS PHARMACEUTICALS INC
CIK 0001454789
Entity typeother
Related Parties
1- filerCIK 0001843393
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:45 PM ET
- Size
- 10.7 KB